Hepatitis B immune globulin
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Hepatitis B immune globulin, covering 2009-02-06 to 2015-04-15. Get the full timeline:
Most recent: Clinical Trial Update: Entecavir Combined Short-term Intravenous Hepatitis B Immune Globulin (HBIG) to Prevent Hepatitis B Recurrence After Liver Transplantation [Phase 4]